- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04015284
Intraoperative Pain and Quality of Surgical Block During Shoulder Surgery Assessed by NOL Index
Intraoperative Pain and Quality of the Surgical Nerve Block During Arthroscopic Shoulder Surgery Assessed by the NOL Index When Comparing the Combined Suprascapular and Posterior Cord Nerve Blocks to the Interscalene Brachial Plexus Block
Postoperative analgesia for shoulder surgery is typically achieved by providing an interscalene brachial plexus block. However, a very common side effect of this block is hemi-diaphragmatic paralysis, a state which may not be tolerated in patients with pulmonary conditions such as COPD. Recently, clinicians have explored new ways to provide satisfactory analgesia while minimizing the pulmonary side effects of the interscalene nerve block. One of these solutions might be to offer the patient a suprascapular nerve block combined to a posterior cord block. Since these blocks are performed lower in the neck or under the clavicle, the phrenic nerve is less likely to be blocked. Thus, fewer respiratory side effects have been reported when using such blocks. This prospective observational study will evaluate the NOL response to surgical stimuli and the opioid requirements intraoperatively in patients undergoing shoulder arthroscopies with either a supraclavicular and posterior cord blocks or an interscalene block.
Study Design: Prospective, randomized open label non-inferiority trial. Subject Population: Adults scheduled to undergo elective shoulder arthroscopy Sample Size: 100 patients Study Duration: Starts February 2019 - Ends February 2021 - Interim analysis at 50 patients Study Center: Maisonneuve-Rosemont Hospital, CEMTL, Montreal, Quebec, Canada
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The main hypothesis of this study is that the suprascapular block combined with a posterior cord block is not inferior to the interscalene brachial plexus block in terms of intraoperative analgesia. We postulate that intraoperative opioid requirements will not differ significantly in patients who receive either block.
Our secondary objectives will consist in looking at the differences in intraoperative anesthetic consumption, NOL index alterations, postoperative opioid consumption, pain scores, arm motor block, diaphragmatic paresis, patient satisfaction and time for readiness to discharge from PACU. We hypothesize that these outcomes will be similar in both groups, with the exception of a potential reduction in arm motor block and diaphragmatic paresis in the combined suprascapular and posterior cord block group.
After having obtained institutional ethics board approval of the study, patients older than 18 years old, scheduled for a first elective shoulder arthroscopy under general anesthesia will be screened in the pre-anesthesia clinic. They will be approached and the whole study procedures will be explained extensively. Interested patients will be invited to sign the consent form (see appendix). Patients will have the right to opt out at any time. The investigators will meet the patients again on the morning of the surgery to address any concerns. After consent, a study number will be allocated to the patient in ascending order.
Two groups will be evaluated:
- Group A: single shot US-guided suprascapular nerve block with 5 mL ropivacaine 0.5%, then single shot US-guided posterior cord block with 10 ml ropivacaine 0.5%.
- Group B: single shot US-guided interscalene brachial plexus block with 15 mL ropivacaine 0.5%.
Tests will be done to evaluate the nerve block-induced loss of sensation to ice prior to entering the operating room (OR). Diaphragmatic excursion will be evaluated using an abdominal curvilinear ultrasound probe, and will be classified as being normal, paradoxical or immobile. Normal motion is caudad movement during inspiration. Paradoxical motion is cephalad movement during inspiration.
Once in the operating room, all routine monitors are connected. Moreover, the PMD TM monitor as well as the BIS® monitor are connected to the anesthesia machine and to the patient. Both study monitors are switched on and will record their respective indices continuously for the duration of the anesthesia. General anesthesia will be induced with propofol (1-2 mg/kg IV; Pharmascience Inc, Canada), remifentanil (1 µg/kg IV bolus; Teva, Canada) and rocuronium (0.6-1 mg/kg IV; Sandoz Canada Inc). A bolus of dexamethasone 4mg IV will be administered after induction of general anesthesia.
Patients will also have received oral acetaminophen 1g and celecoxib 400 mg preoperatively. Intubation with an endotracheal tube is performed once the patient is adequately paralyzed (no responses to the TOF stimulation). All drugs are given according to the adjusted body weight of the patient. This is calculated with Robinson's formula: where TBW is total body weight and IBW is ideal body weight (21-22). Immediately after intubation, anesthesia is maintained with desflurane while targeting a BIS value between 45 and 55, and a remifentanil infusion and boluses are used for a NOL below 25. At the end of anesthesia, when the surgeon starts closing the wounds, an IV bolus of hydromorphone 7 mcg/kg of adjusted body weight is administered. The remifentanil infusion and desflurane are discontinued when dressing starts. Emergence and extubation are done in the OR. All times (start skin closure, start dressing, stop desflurane and remifentanil) will be precisely reported in the CRF.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Montréal, Quebec, Canada, H1T2M4
- Hôpital Maisonneuve-Rosemont, CIUSSS de l'Est de l'Ile de Montréal
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ASA status 1,2,3.
- Age 18 years or older
- Elective shoulder arthroscopic surgery under general anesthesia and nerve block performed preoperatively
Exclusion Criteria:
- Serious cardiac arrhythmias (including atrial fibrillation) or unstable coronary artery disease.
- Coagulation disorders.
- Patient refusal.
- Anatomical disorders and/or neuropathic disease.
- BMI above 40.
- History of substance abuse.
- Chronic use of psychotropic and/or opioid.
- History of psychiatric diseases needing treatment.
- Contraindications to nerve block for shoulder surgery.
- Allergy to remifentanil or any drug in the study protocol.
- Failure of nerve block performed in the preoperative block room
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: SSNB + PCB
Single shot US-guided suprascapular nerve block (SSNB) with 5 mL ropivacaine 0.5%, then single shot US-guided posterior cord block (PCB) with 10 ml ropivacaine 0.5%.
|
The patient lies supine with the head turned to the contralateral side to the block.
Using a linear high-frequency ultrasound probe, the proximal suprascapular nerve is visualized before it turns toward the suprascapular notch.
It is blocked using 5mL of ropivicaine 0.5%.
The posterior cord is readily visualized when performing an infraclavicular brachial plexus block.
It is blocked using 10mL of ropivicaine 0.5%.
Other Names:
|
ACTIVE_COMPARATOR: ISBPB
Single shot US-guided interscalene brachial plexus block (ISBPB) with 15 mL ropivacaine 0.5%.
|
The patient lies supine with the head turned to the contralateral side to the block.
Using a linear high-frequency ultrasound probe, the interscalene groove is visualized along with the roots of the brachial plexus.
The block is performed with 15mL of ropivacaine 0.5%.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dose of remifentanil in mcg/kg/h during the surgery period
Time Frame: Intraoperative from incision until wound dressing
|
The main criterion will be evaluating the dose of remifentanil per kg per hour of surgery needed intraoperatively to keep a NOL index below the threshold of 25.
|
Intraoperative from incision until wound dressing
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to awakening in minutes
Time Frame: Intraoperative
|
Time to awakening in minutes.
|
Intraoperative
|
Time to extubation in minutes
Time Frame: Intraoperative
|
Time to extubation in minutes.
|
Intraoperative
|
Duration of motor block in minutes strength
Time Frame: Postoperative for day 1 H24 24hours after surgery
|
Duration of motor block in minutes, as measured by time to return of normal grip strength.
|
Postoperative for day 1 H24 24hours after surgery
|
NOL response after surgical incisions (area under curve)
Time Frame: Intraoperative
|
NOL response after surgical incisions 1 (located 2 cm inferior and 1 cm medial to posterolateral corner of acromion) of the shoulder (by calculating the area under the curve of NOL for the 5 minutes following incision 1).
|
Intraoperative
|
NOL response after surgical incisions (area under curve)
Time Frame: Intraoperative
|
NOL response after surgical incisions 2 (located slightly inferior to coracoid) of the shoulder (by calculating the area under the curve of NOL for the 5 minutes following incision 1).
|
Intraoperative
|
Total dose remifentanil in mcg
Time Frame: Intraoperative
|
Total dose of remifentanil in mcg from incision until wound dressing
|
Intraoperative
|
Number of remifentanil boluses (n)
Time Frame: Intraoperative
|
Number of remifentanil boluses administered to the patient from incision until wound dressing
|
Intraoperative
|
Desflurance consumption in ml
Time Frame: Intraoperative from incision until wound dressing
|
Intraoperative consumption of desflurane in mL
|
Intraoperative from incision until wound dressing
|
PACU pain scores on a scale from 0 to 10
Time Frame: From entrance in PACU until PACU discharge e.g. up to 3 hours after surgery maximum
|
PACU pain scores
|
From entrance in PACU until PACU discharge e.g. up to 3 hours after surgery maximum
|
Grip strength in mmHg
Time Frame: in PACU e.g. up to 3 hours after surgery maximum
|
Grip strength before nerve blockade and prior to PACU discharge, as measured in mmHg by a pressure transducer connected to a 1000mL saline bag.
|
in PACU e.g. up to 3 hours after surgery maximum
|
Diaphragmatic paresis induced by the nerve block by ultrasound
Time Frame: 30 minutes after nerve block and before general anesthesia and surgery, in awake patient
|
Ipsilateral diaphragmatic excursion 30 minutes after block completion (normal, paradoxical or no movement).
|
30 minutes after nerve block and before general anesthesia and surgery, in awake patient
|
Patient dyspnea on a scale from 0 to 10
Time Frame: PACU e.g. up to 3 hours after surgery maximum
|
Patient dyspnea prior to PACU discharge on a scale from 0 to 10.
|
PACU e.g. up to 3 hours after surgery maximum
|
Time to readiness for discharge from PACU in minutes
Time Frame: PACU e.g. up to 3 hours after surgery maximum
|
Time to readiness for discharge from PACU = time in minutes to reach an Aldrete score at 9 for discharge
|
PACU e.g. up to 3 hours after surgery maximum
|
24h pain scores on a scale from 0 to 10 at rest
Time Frame: Postoperative at H24, 24 hours after surgery
|
24h pain scores, H24
|
Postoperative at H24, 24 hours after surgery
|
48h pain scores on a scale from 0 to 10 at rest
Time Frame: Postoperative at H48, 48 hours after surgery
|
48h pain scores
|
Postoperative at H48, 48 hours after surgery
|
24h pain scores on a scale from 0 to 10 during mobilization
Time Frame: Postoperative at H24, 24 hours after surgery
|
24h pain scores during mobilization
|
Postoperative at H24, 24 hours after surgery
|
Per os postoperative (after PACU discharge) morphine equivalent consumption in mg at 8, 16, 24, 32, 40, 48 hs postoperatively
Time Frame: Postoperative for 2 days 48 hours after surgery
|
Per os opioid consumption in mg of equivalent morphine (every 8 hours by nurses or with a diary in patients with same day surgery).
|
Postoperative for 2 days 48 hours after surgery
|
Patient satisfaction on a scale from 0 to 100
Time Frame: Postoperative at 24h, 24 hours after surgery
|
Patient satisfaction at 24 hours on a scale from 0 to 100.
|
Postoperative at 24h, 24 hours after surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Philippe Richebe, MD, PhD, CIUSSS de l'Est de Montreal
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2019-1743
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shoulder Surgery
-
State University of New York at BuffaloWithdrawnShoulder Surgery | Knee SurgeryUnited States
-
Mansoura UniversityCompleted
-
Severance HospitalCompleted
-
McGill University Health Centre/Research Institute...UnknownShoulder SurgeryCanada
-
Federal University of São PauloUnknownShoulder SurgeryBrazil
-
Mansoura UniversityCompletedShoulder SurgeryEgypt
-
Northwestern UniversityCareFusionCompleted
-
Campbell ClinicCompleted
-
University Hospital MuensterCompletedShoulder SurgeryGermany
-
Diskapi Teaching and Research HospitalUnknownArthroscopic Shoulder Surgery
Clinical Trials on Suprascapular Nerve Block + Posterior Cord Block
-
Istanbul Medeniyet UniversityCompletedPostoperative Pain | Shoulder Pain | Diaphragmatic Paralysis | Suprascapular Nerve Block | Subomohyoid Suprascapular Nerve Block | Anterior Suprascapular Nerve BlockTurkey
-
Bassant M. AbdelhamidCairo UniversityUnknownPostoperative PainEgypt
-
Lawson Health Research InstituteCompletedDisorder of Rotator CuffCanada
-
Bagcilar Training and Research HospitalCompleted
-
Tanta UniversityRecruitingArthroscopic Shoulder Surgery | Anterior Suprascapular Nerve Block | Interscalene Nerve BlockEgypt
-
Hospital Ambroise Paré ParisCompletedPain | Rotator Cuff TearFrance
-
Second Affiliated Hospital of Wenzhou Medical UniversityCompleted
-
Makassed General HospitalRecruiting
-
Diskapi Yildirim Beyazit Education and Research...Completed
-
Ivan SimionatoUnknownPostoperative Pain | Anesthesia, Local | Shoulder Pain | Anesthesia | Rotator Cuff TearsBrazil